Telo Genomics (Germany) Market Value

3D0A Stock  EUR 0.04  0.01  28.57%   
Telo Genomics' market value is the price at which a share of Telo Genomics trades on a public exchange. It measures the collective expectations of Telo Genomics Corp investors about its performance. Telo Genomics is trading at 0.035 as of the 24th of November 2024. This is a 28.57% down since the beginning of the trading day. The stock's lowest day price was 0.035.
With this module, you can estimate the performance of a buy and hold strategy of Telo Genomics Corp and determine expected loss or profit from investing in Telo Genomics over a given investment horizon. Check out Telo Genomics Correlation, Telo Genomics Volatility and Telo Genomics Alpha and Beta module to complement your research on Telo Genomics.
Symbol

Please note, there is a significant difference between Telo Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Telo Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telo Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Telo Genomics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Telo Genomics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Telo Genomics.
0.00
05/28/2024
No Change 0.00  0.0 
In 5 months and 30 days
11/24/2024
0.00
If you would invest  0.00  in Telo Genomics on May 28, 2024 and sell it all today you would earn a total of 0.00 from holding Telo Genomics Corp or generate 0.0% return on investment in Telo Genomics over 180 days. Telo Genomics is related to or competes with Wyndham Hotels, Park Hotels, Sunstone Hotel, InterContinental, and Singapore Airlines. Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological pro... More

Telo Genomics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Telo Genomics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Telo Genomics Corp upside and downside potential and time the market with a certain degree of confidence.

Telo Genomics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Telo Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Telo Genomics' standard deviation. In reality, there are many statistical measures that can use Telo Genomics historical prices to predict the future Telo Genomics' volatility.
Hype
Prediction
LowEstimatedHigh
0.000.0429.23
Details
Intrinsic
Valuation
LowRealHigh
0.000.0329.22
Details
Naive
Forecast
LowNextHigh
0.00060.0329.22
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.030.040.05
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Telo Genomics. Your research has to be compared to or analyzed against Telo Genomics' peers to derive any actionable benefits. When done correctly, Telo Genomics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Telo Genomics Corp.

Telo Genomics Corp Backtested Returns

Telo Genomics is out of control given 3 months investment horizon. Telo Genomics Corp owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0721, which indicates the firm had a 0.0721% return per unit of risk over the last 3 months. We were able to interpolate twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.1% are justified by taking the suggested risk. Use Telo Genomics Corp Risk Adjusted Performance of 0.0686, semi deviation of 21.51, and Coefficient Of Variation of 1302.85 to evaluate company specific risk that cannot be diversified away. Telo Genomics holds a performance score of 5 on a scale of zero to a hundred. The entity has a beta of 4.35, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Telo Genomics will likely underperform. Use Telo Genomics Corp semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and information ratio , to analyze future returns on Telo Genomics Corp.

Auto-correlation

    
  0.01  

Virtually no predictability

Telo Genomics Corp has virtually no predictability. Overlapping area represents the amount of predictability between Telo Genomics time series from 28th of May 2024 to 26th of August 2024 and 26th of August 2024 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Telo Genomics Corp price movement. The serial correlation of 0.01 indicates that just 1.0% of current Telo Genomics price fluctuation can be explain by its past prices.
Correlation Coefficient0.01
Spearman Rank Test-0.15
Residual Average0.0
Price Variance0.0

Telo Genomics Corp lagged returns against current returns

Autocorrelation, which is Telo Genomics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Telo Genomics' stock expected returns. We can calculate the autocorrelation of Telo Genomics returns to help us make a trade decision. For example, suppose you find that Telo Genomics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Telo Genomics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Telo Genomics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Telo Genomics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Telo Genomics stock over time.
   Current vs Lagged Prices   
       Timeline  

Telo Genomics Lagged Returns

When evaluating Telo Genomics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Telo Genomics stock have on its future price. Telo Genomics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Telo Genomics autocorrelation shows the relationship between Telo Genomics stock current value and its past values and can show if there is a momentum factor associated with investing in Telo Genomics Corp.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Telo Stock

Telo Genomics financial ratios help investors to determine whether Telo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Telo with respect to the benefits of owning Telo Genomics security.